Patent US5043323A successfully refreshed from Google Patents.
← Back to Patent Explorer
US5043323A Expired / Lapsed US ⏱️ 0.0 years remaining

Complex compounds of bioflavonoids with phospholipids, their preparation and use, and pharmaceutical and cosmetic compositions containing them

Assignee: Indena SpA
•
Filing: 1988-01-12
•
Granted: 1991-08-27
•
Expires: 2008-01-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Complex compounds of flavonoids with phospholipids, characterized by high lipophilia and improved bio-availability and therapeutic properties as compared with free, not complexed flavonoids. The complex compounds of the invention are suitable for use as the active principle in pharmaceutical and cosmetic compositions.

Inventors

  • 👤 Ezio Bombardelli
  • 👤 Gian F. Patri

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 17:04
CPC Classifications
C; C07; C07F; C07F9/00; C07F9/02; C07F9/06; C07F9/08; C07F9/09; C07F9/10; C07F9/106; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/54; A61K47/543; A61K47/544; A61K8/00; A61K8/18; A61K8/30; A61K8/55; A61K8/553; A61K8/60; A61K8/602; A61K8/96; A61K8/97; A61K8/9771; A61K8/9783; A61K8/9789; A61P; A61P29/00; A61P3/00; A61P9/00; A61P9/08; A61Q; A61Q19/00; C07H; C07H17/00; C07H17/04; C07H17/06; C07H17/065; C07H17/07

Claims Analysis

Total Claims: 19
Claim 1
Independent Claim 106 words
A complex of a flavonoid with a phospholipid wherein the flavonoid is a member selected from the group consisting of quercetin, kaempferol, quercetin-3-ramnoglucoside, quercetin-3-ramnoside, quercetin-3-glucoside, hyperoside, (+) apigenin, apigenin-7-glucoside, luteolin, luteolin-glucoside ramnoglucoside, 5,7,3',4'-pentahydroxy-flavone-3D-alfa-rhamnopyranosyl-4-D-beta-O-(6"-transcoumaroyl-)glucopyranoside, 3,4,5,4'-tetrahydroxy-flavone-3-D-alfa-rhamnopyranosyl-4-D-beta-O-(6"-trans-coumaroyl-)glucopyranoside, Ginkgonetine, Isoginkgonetine, Sciedopitasine, rutine and Bilobetine, and the phospholipid is a member selected from the group consisting of soy lecithins, egg lecithin phospholipids from bovine or swine brain or dermis, phosphatidyl choline, phosphatidyl serine, phosphatidyl ethanolamine in which the acyl groups are the same or different and are derived from palmitic, stearic, oleic, linoleic, linolenic acid, and wherein the phospholipid to flavonoid ratio is in the molar range from 0.5 to 2M.
Claim 2
Dependent Claim 106 words
A complex of a flavonoid with a phospholipid wherein the flavonoid is a member selected from the group consisting of quercetin, kaempferol, quercetin-3-ramnoglucoside, quercetin-3-ramnoside, quercetin-3-glucoside, hyperoside, (+) apigenin, apigenin-7-glucoside, luteolin, luteolin-glucoside ramnoglucoside, 5,7,3',4'-pentahydroxy-flavone-3D-alfa-rhamnopyranosyl-4-D-beta-O-(6"-transcoumaroyl-)glucopyranoside, 3,4,5,4'-tetrahydroxy-flavone-3-D-alfa-rhamnopyranosyl-4-D-beta-O-(6"-trans-coumaroyl-)glucopyranoside, Ginkgonetine, Isoginkgonetine, Sciedopitasine, rutine and Bilobetine, and the phospholipid is a member selected from the group consisting of soy lecithins, egg lecithin phospholipids from bovine or swine brain or dermis, phosphatidyl choline, phosphatidyl serine, phosphatidyl ethanolamine in which the acyl groups are the same or different and are derived from palmitic, stearic, oleic, linoleic, linolenic acid, and wherein the phospholipid to flavonoid ratio is in the molar range from 0.5 to 2M.
Claim 3
Dependent Claim 13 words
The complex according to claim 1 which is the quercetin/di-stearoyl phosphatidylcholine equimolecular complex.
Claim 4
Dependent Claim 13 words
The complex according to claim 1 which is the quercetin-3-galactoside/soy phosphatidylcholine equimolecular complex.
Claim 5
Dependent Claim 12 words
The complex according to claim 1 which is the quercetin-3-rhamnoglycoside/soy hosphatidylcholine complex.
Claim 6
Dependent Claim 11 words
The complex according to claim 1 which is the kaempferol-3-glycoside/soy phosphatidylcholine.
Claim 7
Dependent Claim 12 words
The complex according to claim 1 which is the vitexine-2"-rhamnoside-2"-acetate/soy phosphatidylcholine complex.
Claim 8
Dependent Claim 14 words
The complex according to claim 1 which is the Ginkgo biloba extract/soy phosphatidylcholine complex.
Claim 9
Dependent Claim 12 words
The complex according to claim 1 which is the apigenin/soy phosphatidylethanolamine complex.
Claim 10
Dependent Claim 10 words
The complex according to claim 1 which is apigenin/distearoylphosphatidylcholine complex.
Claim 11
Dependent Claim 11 words
The complex according to claim 1 which is luteolin-7-glycoside/soy phosphatidylcholine complex.
Claim 12
Dependent Claim 11 words
The complex according to claim 1 which is diosmin/soy phosphatidylcholine complex.
Claim 13
Dependent Claim 15 words
The complex according to claim 1 which is Gingko biloba depurated extract/total soy phospholipids complex.
Claim 14
Dependent Claim 11 words
The complex according to claim 1 which is Hawthorn/soy phosphatidylcholine complex.
Claim 15
Dependent Claim 39 words
A cosmetic composition for topical application containing 0.1-10% by weight as the active principle or a complex according to claim 13 in the form of a solution, powder, cream, gel, or as an aqueous microdispersion, with pharmaceutically acceptable carriers.
Claim 16
Dependent Claim 19 words
The composition according to claim 14 wherein said active principle is the Gingko biloba depurated extract/total soy phospholipids complex.
Claim 17
Dependent Claim 14 words
The composition according to claim 14 wherein the active principle is luteolin-7-glycoside/soy phosphatidylcholine complex.
Claim 18
Dependent Claim 14 words
The composition according to claim 14 wherein the active principle is luteolin-7-glycoside/soy phosphatidylcroline complex.
Claim 19
Dependent Claim 18 words
The composition according to claim 14 wherein the active principle is a phospholipid complex from luteolin or rutin.

References Cited (Backward Citations)

US4358442A Cited
EP0161445A1 Cited
US4769508A Cited
JPH01152632A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1994-08-26 1995-02-25 1995-08-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1998-08-26 1999-02-25 1999-08-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2002-08-26 2003-02-25 2003-08-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag